Metropolitan Life Insurance CO Eloxx Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$4.37 - $9.91 $44,451 - $100,804	-10,172 Closed	0 $0
Q2 2019 Jul 12, 2023	BUY	$8.77 - $12.49 $89,208 - $127,048	10,172 New	10,172 $101,000
Q1 2019 Jul 13, 2023	BUY	$10.45 - $13.94 $106,297 - $141,797	10,172 New	10,172 $118,000
Q1 2019 Mar 30, 2023	BUY	$10.45 - $13.94 $106,297 - $141,797	10,172 New	10,172 $118,000
Q1 2019 May 16, 2019	BUY	$10.45 - $13.94 $9,906 - $13,215	948 Added 10.28%	10,172 $118,000
Q1 2019 May 15, 2019	SELL	$10.45 - $13.94 $9,906 - $13,215	-948 Reduced 9.32%	9,224 $338,000
Q4 2018 Jul 13, 2023	BUY	$10.43 - $17.39 $106,093 - $176,891	10,172 New	10,172 $122,000
Q4 2018 Feb 14, 2019	BUY	$10.43 - $17.39 $82,855 - $138,146	7,944 Added 356.55%	10,172 $122,000
Q3 2018 Jul 13, 2023	BUY	$11.95 - $19.63 $121,555 - $199,676	10,172 New	10,172 $173 Million
Q3 2018 Nov 14, 2018	BUY	$11.95 - $19.63 $26,624 - $43,735	2,228 New	2,228 $38,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.